To this end, we examined the serum AFP values and ultrasonic results obtained at the time of HCC detection in a hospital-based cohort of patients undergoing regular surveillance in the absence of cancer-related symptoms, and then assessed survival outcomes according to diagnostic status. This evidence concerns the gene AFP and cancer.